ArriVent BioPharma (AVBP) Appoints Merdad Parsey to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ACCV
3. SPY
4. QQQ
5. AZN
6. FICO
7. SMMT
8. GMAB
9. SAIQ
10. IVBIY

Go back to ArriVent BioPharma (AVBP) Appoints Merdad Parsey to its Board

ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

April 28, 2025 8:00 AM EDT

NEWTOWN SQUARE, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Merdad Parsey, M.D., Ph.D. to its Board of Directors. Dr. Parsey brings decades of executive experience leading global clinical development in the biopharmaceutical industry, most recently serving as Chief Medical Officer and Executive Vice President of Gilead Sciences, Inc.

Dr. Parsey is a seasoned executive who has driven therapeutic innovation and strategic growth at prominent pharmaceutical... More